Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin lock concentration comparison in hemodialysis permcath patients
IRCT20211003052657N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of heparin in Hemodialysis and catheter-related thrombosis (CRT) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Catheter thrombosis and Bleeding. Started Oct 2021; status: completed.
02
Drugs
heparin
03
Conditions
Hemodialysiscatheter-related thrombosis (CRT)
Beyond the preview
Go deeper on IRCT20211003052657N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211003052657N1.